The World Health Organization’s (WHO) HIV department has asked aidsmap.com to clarify the status of funding for its antiretroviral pharmacovigilance programme, details of which we reported in an article WHO to monitor ARV side-effects worldwide on June 18th. We incorrectly reported that funding had already been agreed for this initiative.
WHO said today: “The HIV Department has a proposal to part-fund this global initiative with the Gates Foundation, and this is currently under review. WHO is in close dialogue with the Foundation but would like to clarify that no decision has been made as to whether the proposal will be funded or not"